… of visual impairment due to neovascular (wet) age-related macular degeneration (wAMD). This is the second indication for Eylea approved in China, …



Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *